Decision for tPA Administration, Not Response Time, Contributes Most to Variation in Thrombolysis Times Onboard Mobile Stroke Unit

溶栓时间差异的主要影响因素是tPA给药决策,而非反应时间。在移动卒中单元中,溶栓时间差异最大的因素是tPA给药决策。

阅读:1

Abstract

BACKGROUND: Hospitals have improved stroke thrombolysis times through rigorous assessment of care delays. However, this same rigor has not yet been applied to the novel setting of mobile stroke units (MSUs). METHODS: We reviewed all cases of intravenous tPA (tissue-type plasminogen activator) administration onboard our MSU in Rochester, NY, since its first complete year of operation in 2019. The dispatch timeline was divided into 6 intervals: (1) response time, (2) onboarding time, (3) head computed tomography collection, (4) head computed tomography reading, (5) decision time, and (6) intravenous tPA administration. RESULTS: The mean±SD total time between MSU dispatch and tPA was 42±8.4 minutes (range, 26-60 minutes; N=53). The largest mean duration was in (1), between dispatch and arrival (12.0±4.7 minutes). However, the intercase variation was greatest in (5), between head computed tomography reading and treatment decision (6.3±6.2 minutes). After ranking cases by total time, the mean decision times of first and fourth quartile cases varied the most, by a factor of 2.45, whereas the mean times for the other intervals varied by <1.50. Decision time was the interval most closely correlated with the mean total time (Spearman ρ=0.46; P=0.00051), which significantly decreased from 2019 to 2020 (Mann-Whitney, Z=2.38; P=0.02). Decision time was negatively correlated with time since inception of the MSU (Spearman ρ=-0.29; P=0.037; Figure 2B), suggesting that decision time drove both variations and improvements in overall thrombolysis time. CONCLUSIONS: The primary driver of variation in total time from emergency alert to tPA administration is provider decision time in our MSU program in Rochester, NY. This observation should be investigated in other settings but may ultimately inform MSU training and staffing to optimize MSU treatment timelines.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。